Why NewBeauty Readers Love Irene Forte Hibiscus Night Cream

Now that 2025 is officially in the books, we’re finally able to look back at the products that truly defined the year for our readers. And while new launches came fast, only a handful earned the kind of loyalty that lasts well beyond a product’s first empty jar. So when we asked more than 400 NewBeauty readers* to name their favorite beauty product of 2025, one night cream rose to the top with impressive consistency: Irene Forte Hibiscus Night Cream ($170).

Known for its luxurious texture and regenerative benefits, the cream has become a nighttime staple for women who want results that feel both indulgent and intentional—it’s also a consistent best-seller for the luxe brand. Here’s why.  

What’s in the Formula

At the center of the cream is Myoxinol, a neuropeptide extracted from hibiscus seeds that’s proven to deliver younger-looking skin in just 10 days. It’s supported by green pea polypeptides for firmness, hyaluronic acid for deep hydration, and a blend of omega-rich oils and ceramides that replenish moisture and strengthen the skin barrier overnight.

What Readers Are Saying

Our respondents didn’t hold back when describing why this night cream earned their loyalty. A 51‑year‑old reader told us it “smells divine and keeps my skin hydrated, dewy and polished,” while a 59‑year‑old said she loves that it’s “creamy but doesn’t make your face break out,” adding that the scent is a standout. Another reader, 58, praised it for being “very hydrating and regenerative,” a sentiment echoed across many responses.

BUY ON DERMSTORE – $170

BUY ON REVOLVE – $225

The Bottom Line

No matter their age, readers kept coming back to the same themes: a rich‑but‑not‑heavy texture, a scent that makes the nightly ritual feel indulgent, and real overnight moisture that doesn’t clog pores. It’s the kind of formula that wins people over on both experience and results. If you’re looking for a new night cream, you may have just hit the jackpot. 

*Source: BeautyEngine Advanced Research, 2026